Post-approval studies (Phase 4)WithdrawnNCT00771043
What this trial is testing
A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
Who this might be right for
Relapsing-remitting Multiple Sclerosis
Biogen